联系客服

600511 沪市 国药股份


首页 公告 国药股份:600511_国药股份_2023年_非经营性资金占用及其他关联资金往来情况

国药股份:600511_国药股份_2023年_非经营性资金占用及其他关联资金往来情况

公告日期:2024-03-21

国药股份:600511_国药股份_2023年_非经营性资金占用及其他关联资金往来情况 PDF查看PDF原文

        关于国药集团药业股份有限公司

    非经营性资金占用及其他关联资金往来情况

            汇总表的专项审计报告

目 录
1、 专项审计报告
2、 附表
委托单位:国药集团药业股份有限公司
审计单位:普华永道中天会计师事务所(特殊普通合伙)
联系电话:010-67271828

附表 2

                                  关于国药集团药业股份有限公司

                        2023 年度非经营性资金占用及其他关联资金往来情况表

                                                                                                                          单位:万元

                              占用方与上市  上市公司  2023 年期  2023 年度  2023 年度  2023 年度  2023 年期

 非经营性资金占  资金占用方  公司的关联关  核算的会  初占用资  占用累计发  占用资金  偿还累计发  末占用资  占用形成  占用性质
      用            名称          系        计科目    金余额  生金额(不  的利息    生金额    金余额      原因

                                                                    含利息)    (如有)

现控股股东、实  不适用                                                                                                    非经营性
际控制人及其附                                                                                                                占用
属企业                                                                                                                      非经营性
                                                                                                                              占用

    小计            /            /          /                                                                  /        /

前控股股东、实  不适用                                                                                                    非经营性
际控制人及其附                                                                                                              占用

属企业                                                                                                                      非经营性
                                                                                                                            占用

    小计            /            /          /                                                                  /        /

                  不适用                                                                                                    非经营性
其他关联方及其                                                                                                              占用

附属企业                                                                                                                    非经营性
                                                                                                                            占用

    小计              /              /            /                                                                      /          /

    总计            /            /          /                                                                  /        /

 其他关联资金往  资金往来方  往来方与上市  上市公司  2023 年期  2023 年度  2023 年度  2023 年度  2023 年期  往来形成

      来            名称      公司的关系  核算的会  初往来资  往来累计发  往来资金  偿还累计发  末往来资    原因    往来性质
                                              计科目    金余额  生金额(不  的利息    生金额    金余额


                                                                    含利息)  (如有)

                  国药控股四川  与本集团同受                                                                                经营性往
                  医药股份有限  控股股东控制  应收账款    4,468.28    27,024.49          -    26,542.11    4,950.66  销售商品  来

                  公司

                  国药乐仁堂医  与本集团同受  应收账款    3,590.39    26,091.20          -    25,210.61    4,470.98  销售商品  经营性往
                  药有限公司    控股股东控制                                                                                      来

                  国药控股陕西  与本集团同受  应收账款    2,185.27    18,666.37          -    18,175.56    2,676.08  销售商品  经营性往
                  有限公司      控股股东控制                                                                                      来

                  国药控股广西  与本集团同受  应收账款      603.02    13,902.93          -    12,163.78    2,342.17  销售商品  经营性往
                  有限公司      控股股东控制                                                                                      来

                  国药控股河南  与本集团同受  应收账款    1,150.12    24,389.36          -    23,293.65    2,245.83  销售商品  经营性往
                  股份有限公司  控股股东控制                                                                                      来

                  国药集团新疆  与本集团同受                                                                                      经营性往
                  新特药业有限  控股股东控制  应收账款    2,874.60    21,862.70          -    22,511.51    2,225.79  销售商品  来

                  公司

控股股东、实际  国药控股湖北  与本集团同受  应收账款    1,931.41    15,184.93          -    15,017.26    2,099.08  销售商品  经营性往
控制人及其附属  有限公司      控股股东控制                                                                                      来

企业              国药控股股份  控股股东      应收账款    1,625.33    17,019.74          -    16,726.44    1,918.63  销售商品  经营性往
                  有限公司                                                                                                        来

                  国药控股广州  与本集团同受  应收账款    1,215.11    23,733
[点击查看PDF原文]